Lisata Therapeutics Inc.

NASDAQ: LSTA · Real-Time Price · USD
2.52
-0.04 (-1.56%)
At close: Aug 15, 2025, 3:59 PM
2.53
0.40%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lisata Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1M n/a 121.37M n/a
Cost of Revenue
174K 189K 69K 55K
Gross Profit
1M -189K 63.77M -55K
Operating Income
-22.41M -25.71M -57.6M -29.05M
Interest Income
1.88M 2.72M 1.05M 151K
Pretax Income
-20.78M -23.17M -56.7M -28.97M
Net Income
-19.98M -20.84M -54.23M -27.47M
Selling & General & Admin
12.07M 12.97M 14.14M 11.37M
Research & Development
11.33M 12.73M 43.46M 17.68M
Other Expenses
n/a -189K n/a n/a
Operating Expenses
23.41M 25.52M 57.6M 29.05M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
23.41M 25.71M 57.6M 29.05M
Income Tax Expense
-798K -2.33M -2.48M -1.51M
Shares Outstanding (Basic)
8.33M 8.07M 5.18M 3.69M
Shares Outstanding (Diluted)
8.33M 8.07M 5.18M 3.69M
EPS (Basic)
-2.4 -2.58 -10.47 -7.45
EPS (Diluted)
-2.4 -2.58 -10.47 -7.45
EBITDA
-22.23M -25.52M -56.63M -29M
EBIT
-22.41M -23.17M -56.7M -29.05M
Depreciation & Amortization
174K 189K 69K 55K